Skip to content

Efficacy of patient own amniotic membrane in primary caesarean wound healing

Efficacy of autologous human amniotic membrane patch dressing in primary caesarean wound healing - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062235
Enrollment
100
Registered
2024-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O82- Encounter for cesarean delivery without indication

Interventions

Intervention1: Autologous human amniotic membrane dressing on primary cesarean wound: Human amniotic membrane will be prepared from autologous placenta and the membrane will be used as dressing on pri

Sponsors

University College of Medical Sciences and Guru Teg Bahadur Hospital Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Pregnant women of any age and parity with gestational age more than 28 weeks scheduled for primary caesarean section. • Patients who are willing to follow up in UCMS & GTB Hospital.

Exclusion criteria

Exclusion criteria: 1. Patients with infections like Hepatitis B, Hepatitis C, HIV, Syphilis. 2. Patients with leaking per vaginum more than 18 hours or chorioamnionitis. 3. Any febrile illness. 4. Patients with moderate to severe anemia (Hb less than 10 gm%) or thrombocytopenia. 5. Any dermatological infection around surgical site.

Design outcomes

Primary

MeasureTime frame
REEDA (Redness, Edema, Ecchymosis, Discharge, Approximation) score in HAM dressing & non-HAM dressing group.Timepoint: Day 3, day 8 & day 42

Secondary

MeasureTime frame
1. Total number of patients with superficial & deep caesarean site infection in both the groups. 2. Adverse events like pain, swelling, discharge, dehiscence in both the groups. 3. Organisms associated with caesarean surgical site infection in both the groups. 4. Total length of hospital stay due to wound morbidity in both the groups.Timepoint: Day 3, day 8 & day 42

Countries

India

Contacts

Public ContactNiketa Chaudhary

University College of Medical Sciences and GTB Hospital

gautamdrricha1@gmail.com7011484180

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026